Optimal therapeutic dose and time window of picroside II in cerebral ischemic injury

Neural Regeneration Research

Volumn 9, Issue 15, 2014, Pages 1437-1445

  Liu, Guang Yi ^a   Zhao, Li ^a   Wang, Ting Ting ^a   Zhang, Mei Zeng ^a   Pei, Hai Tao ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Brain ischemia; Flow cytometry; Immunohistochemical assay; Nerve regeneration; Neural regeneration; Neuron specific enolase; NSFC grant; Picroside II; Rats; RT PCR; Therapeutic dose; Time window; Toluidine blue staining; Western blot

Indexed keywords

NEURON SPECIFIC ENOLASE; PICROSIDE II; PLANT GLYCOSIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84907149282     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.139460     Document Type: Article

References (40)

1. Al-Rawi NH, Atiyah KM (2009) Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients. Clin Chem Lab Med 47:1519-1524.
2. Anand N, Stead LG (2005) Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Dis 20:213-219.
3. Bharosay A, Bharosay VV, Varma M, Saxena K, Sodani A, Saxena R (2012) Correlation of brain biomarker neuron specific enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke. Indian J Clin Biochem 27:186-190.
4. Brea D, Sobrino T, Blanco M, Cristobo I, Rodriguez-Gonzalez R, Rodriguez-Yanez M, Moldes O, Agulla J, Leira R, Castillo J (2009) Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med 47:1513-1518.
5. Brouns R, De Vil B, Cras P, De Surgeloose D, Marien P, De Deyn PP (2010) Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin Chem 56:451-458.
6. Fan YQ (2011) Clinical significance to detect 6-keto-PGF1α and NSE in Neonatal hypoxia-ischemic encephalopathy. Zhonghua Quanke Yixue 9:1952-1953.
7. Gonzalez-Garcia S, Gonzalez-Quevedo A, Fernandez-Concepcion O, Pena-Sanchez M, Menendez-Sainz C, Hernandez-Diaz Z, Arteche-Prior M, Pando-Cabrera A, Fernandez-Novales C (2012) Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients. Clin Biochem 45:1302-1307.
8. Guo Y, Xu X, Li Q, Li Z, Du F (2010) Anti-inflammation effects of picroside II in cerebral ischemic injury rats. Behav Brain Funct 6:43-53.
9. Guo YL, Shen W, Du F, Li Q, Li Z (2011) The interference of picroside II on the expressions of TLR4 and NFκB following cerebral ischemia reperfusion injury in rats. Chin J Integr Med 31:58-61.
10. Hein Nee Maier K, Kohler A, Diem R, Sattler MB, Demmer I, Lange P, Bahr M, Otto M (2008) Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis. Neurosci Lett 436:72-76.
11. Hou L, Pu HP, Shao BQ (2003) Effects of ginkgo biloba extract on expressions of NSE S-100 mRNA in newborn rat brain with hypoxic-ischemic brain damage. Chin Phar Bull 19:100-102.
12. Huang WX, Li YQ, Liu JY, Huang JS (2012) The expression and clinical significance of neurone specific enolase in patients with ischemic cerebral vascular disease. Zhonghua Quanke Yixue 10:1225-1226.
13. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR; NINDS rt-PA Stroke Study Group (2006) Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 37:2508-2513.
14. Ji YB, Wu YM, Ji Z, Song W, Xu SY, Wang Y, Pan SY (2012) Interrupted intracarotid artery cold saline infusion as an alternative method for neuroprotection after ischemic stroke. Neurosurg Focus 33:E10.
15. Jiangsu new medical college Chinese medicine dictionary editorial (1996) Traditional Chinese medicine dictionary (part II). Shanghai: Shanghai Science and Technology Press 1548-1550.
16. Jickling GC, Sharp FR (2011) Blood biomarkers of ischemic stroke. Neurotherapeutics 8:349-360.
17. Kaca-Oryńska M, Tomasiuk R, Friedman A (2010) Neuron-specific enolase and S 100B protein as predictors of outcome in ischemic stroke. Neurol Neurochir Pol 44:459-463.
18. Li P, Matsunaga K, Yamakuni T, Ohizumi Y (2002a) Picrosides I and II, selective enhancers of the mitogen-activated protein kinase-dependent signaling pathway in the action of neuritogenic substances on PC12D cells. Life Sci 71:1821-1835.
19. Li Q, Guo YL, Li Z, Xu XY (2010b) The interference of picroside II on the expressions of Caspase-3 and PARP following cerebral ischemia reperfusion injury in rats. Chin Phar Bull 26:342-345.
20. Li Q, Li Z, Xu XY, Du F (2010c) Neuroprotective properties of picroside II in rat model of focal cerebral ischemia. Int J Mol Sci 11:4580-4590.
21. Li T, Liu JW, Zhang XD, Guo MC, Ji G (2007d) The neuroprotective effect of picroside II from hu-huang-lian against oxidative stress. Am J Chin Med 35:681-691.
22. Li Z, Li Q, Guo YL, Qin LH, Luan LJ (2010e) Intervention effect of picroside II in cerebral ischemic injury rats. Acta Anat Sin 41:9-12.
23. Li Z, Li Q, Shen W, Guo YL (2010f) The interference of picroside II on the expressions of NFκB and IκB following cerebral ischemia reperfusion injury in rats. Chin Phar Bull 26:52-55.
24. Lima JE, Takayanagui OM, Garcia LV, Leite JP (2004) Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders. Braz J Med Biol Res 37:19-26.
25. Liu RJ, Zhang XY, Wen CW, Tang J (2010) The study of orthogonal experiment design and analysis method. Shiyan Jishu yu Guanli 27:52-55.
26. Marquardt G, Setzer M, Szelenyi A, Seifert V, Gerlach R (2009) Prognostic relevance of serial S100B and NSE serum measurements in patients with spinal intradural lesions. Neurol Res 31:265-269.
27. Marquez-Martin A, Jimenez-Altayo F, Dantas AP, Caracuel L, Planas AM, Vila E (2012) Middle cerebral artery alterations in a rat chronic hypoperfusion model. J Appl Physiol 112:511-518.
28. Meng FJ, Hou ZW, Li Y, Yang Y, Yu B (2012) The protective effect of picroside II against hypoxia/reoxygenation injury in neonatal rat cardiomyocytes. Pharm Biol 50:1226-1232.
29. Oksanen T, Tiainen M, Skrifvars MB, Varpula T, Kuitunen A, Castren M, Pettila V (2009) Predictive power of serum NSE and OHCA score regarding 6-month neurologic outcome after of hospital ventricular fibrillation and therapeutic hypothermia. Resuscitation 80: 165-170.
30. Pei HT, Su X, Zhao L, Li H, Guo YL, Zhang M, Xin H (2012) Primary study for the therapeutic dose and time window of picroside II in treating cerebral ischemic injury in rats. Int J Mol Sci 13:2551-2562.
31. Saenger AK, Christenson RH (2010) Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem 56:21-33.
32. Selakovic V, Raicevic R, Radenovic L (2005) The increase of neuron- specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 12:542-547.
33. Sienkiewicz-Jarosz H, Gałecka-Wolska M, Bidziński A, Turzyńska D, Sobolewska A, Lipska B, Płaźnik A, Ryglewicz D (2009) Predictive value of selected biochemical markers of brain damage for functional outcome in ischemic stroke patients. Neurol Neurochir Pol 43:126-133.
34. Singh HV, Pandey A, Shrivastava AK, Raizada A, Singh SK, Singh N (2013) Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta 419:136-138.
35. van Munster BC, Korse CM, de Rooij SE, Bonfrer JM, Zwinderman AH, Korevaar JC (2009) Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol 9:21.
36. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM (2004) Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62:1303-1310.
37. Whiteley W (2011) Identifying blood biomarkers to improve the diagnosis of stroke. J R Coll Physicians Edinb 41:152-154.
38. Whiteley W, Chong WL, Sengupta A, Sandercock P (2009) Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 40:e380-389.
39. Wu YC, Zhao YB, Lu CZ, Qiao J, Tan YJ (2004) Correlation between serum level of neuron-specific enolase and long-term functional outcome after acute cerebral infarction: prospective study. Hong Kong Med J 10:251-254.
40. Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M (2006) Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and longterm outcome in acute ischemic stroke. Clin Neurol Neurosurg 108:558-563.